Flagship explainer
How PUMA BIOTECHNOLOGY, INC. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $228M | 100% |
| |
| Cost of revenue | $58.2M | 25% |
|
| $170M | 75% |
| |
| $37.3M | 16% |
| |
| Income before tax | $35.8M | 16% |
|
| Income tax | $4.7M | 2% |
|
| $31.1M | 14% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001437749-26-005891